Lactose
102.00
-2.15(-2.06%)
Market Cap₹128.39 Cr
PE Ratio21.61
IndustryHealthcare
Company Performance:
1D-2.06%
1M-15.95%
6M-8.89%
1Y+1.49%
5Y+195.22%
View Company Insightsright
More news about Lactose
16Jan 26
SST Private Family Trust Completes SEBI Disclosure for Lactose India Stake Transfer
SST Private Family Trust filed comprehensive regulatory disclosure with SEBI on January 14, 2026, regarding its completed acquisition of 4.57% stake in Lactose (India) Limited. The inter-se transfer from Madhusha Lifecare Private Limited was executed at ₹61.00 per share on December 17, 2025, with all regulatory compliance requirements met within prescribed timelines.
 no imag found
24Oct 25
Lactose India Limited's Credit Rating Reaffirmed at CRISIL BBB-/Stable
CRISIL Ratings Limited has reaffirmed the BBB-/Stable credit rating for Lactose India Limited's long-term bank facilities totaling Rs. 60.00 crore from Bank of Baroda. The rating covers cash credit, proposed working capital facilities, and term loans. The rating indicates moderate safety for timely servicing of financial obligations with moderate credit risk. The rating is valid until March 31, 2026.
 no imag found
23Aug 25
Lactose (India) Limited Secures BSE Approval for Vitanosh Ingredients Merger
Lactose (India) Limited has received a no-objection observation letter from BSE Limited for its proposed merger with Vitanosh Ingredients Private Limited. The BSE issued the letter on August 22, 2025, containing no adverse observations. The merger scheme, approved by the Board of Directors in October 2024, falls under Sections 230 to 232 of the Companies Act, 2013. While this is a significant step, the merger still requires additional regulatory and statutory approvals. The company has made the BSE observation letter available on its website for transparency.
 no imag found
Lactose
102.00
-2.15
(-2.06%)
1 Year Returns:+1.49%
Industry Peers
Sun Pharmaceutical
1,868.00
(+0.27%)
Divis Laboratories
6,747.00
(-0.60%)
Torrent Pharmaceuticals
4,514.10
(+1.28%)
Cipla
1,433.10
(+1.23%)
Zydus Life Science
1,112.20
(+2.46%)
Dr Reddys Laboratories
1,301.30
(+0.82%)
Lupin
2,357.80
(+0.76%)
Mankind Pharma
2,528.60
(-0.38%)
Aurobindo Pharma
1,534.20
(+2.84%)
Laurus Labs
1,481.00
(+3.14%)